Suppliers / Grindeks

Grindeks

Latvia 3 duplicate records merged Updated 9 July 2026

Grindeks is an API and finished-dose manufacturer based in Latvia. It appears in 545 regulatory filings across 14 regulators, without an active US DMF or CEP on file. Its filings concentrate with AIFA (IT), FAMHP (BE) and INFARMED (PT).

0
active US DMFs
0
valid CEPs
0
registered plants
545
filings across 14 regulators

What they file, and where

Molecule Regulators Docs
Dexmedetomidine SFDA (Saudi Arabia) 1

Also appears on these molecule pages

Filings and GMP by regulator

Regulator Filings GMP certificates
AIFA (IT) 218 None
FAMHP (BE) 68 None
INFARMED (PT) 61 None
MPA (SE) 55 None
RAMA (GE) 38 None
NCELS (KZ) 38 None

Questions about Grindeks

Does Grindeks hold a US DMF or a CEP?
No active US drug master file or valid CEP is on record for Grindeks. It does have 545 filings with 14 regulators, so it is registered, just not with the two strong registers buyers usually screen on.
What does Grindeks make?
1 molecule is on record against Grindeks, including Dexmedetomidine. Each links through to that molecule's full manufacturer list.
Where does Grindeks file?
Filings are on record with AIFA (IT), FAMHP (BE), INFARMED (PT), MPA (SE) and 10 other regulators, 545 in total.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Grindeks comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability